AMLX icon

Amylyx Pharmaceuticals
AMLX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$25
72% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
80% 1-yr AMLX win rate
4 Mar ‘26 yesterday
Stifel
Stifel
James Condulis
0% 1-yr AMLX win rate
3 Mar ‘26 2 days ago
BofA Securities
BofA Securities
Geoff Meacham
80% 1-yr AMLX win rate
20 Feb ‘26 13 days ago